VanEck Pharmaceutical ETF
PPH
PPH
49 hedge funds and large institutions have $131M invested in VanEck Pharmaceutical ETF in 2018 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $920K
Holders
49
Holding in Top 10
–
Calls
–
Puts
$920K
Top Buyers
| 1 | +$9.34M | |
| 2 | +$8.93M | |
| 3 | +$1.77M | |
| 4 |
VF
Virtu Financial
New York
|
+$1.45M |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$523K |
Top Sellers
| 1 | -$4.52M | |
| 2 | -$1.45M | |
| 3 | -$1.03M | |
| 4 |
CCT
Country Club Trust
Kansas City,
Missouri
|
-$890K |
| 5 |
MA
Mutual Advisors
Omaha,
Nebraska
|
-$823K |